モダリスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/08/18 | 1,324 | 1,359 | 1,286 | 1,320 | +19 | +1.5% | 308,300 |
| 2021/08/17 | 1,320 | 1,332 | 1,275 | 1,301 | -27 | -2% | 193,000 |
| 2021/08/16 | 1,229 | 1,337 | 1,211 | 1,328 | +115 | +9.5% | 372,200 |
| 2021/08/13 | 1,205 | 1,308 | 1,198 | 1,213 | +13 | +1.1% | 421,900 |
| 2021/08/12 | 1,210 | 1,218 | 1,133 | 1,200 | -17 | -1.4% | 309,100 |
| 2021/08/11 | 1,180 | 1,260 | 1,180 | 1,217 | +37 | +3.1% | 334,100 |
| 2021/08/10 | 1,116 | 1,192 | 1,115 | 1,180 | +66 | +5.9% | 622,500 |
| 2021/08/06 | 1,093 | 1,195 | 1,081 | 1,114 | -189 | -14.5% | 656,400 |
| 2021/08/05 | 1,377 | 1,386 | 1,298 | 1,303 | -74 | -5.4% | 235,000 |
| 2021/08/04 | 1,435 | 1,441 | 1,344 | 1,377 | -58 | -4% | 165,900 |
| 2021/08/03 | 1,409 | 1,461 | 1,409 | 1,435 | +5 | +0.3% | 65,000 |
| 2021/08/02 | 1,417 | 1,472 | 1,417 | 1,430 | -47 | -3.2% | 110,800 |
| 2021/07/30 | 1,485 | 1,485 | 1,423 | 1,477 | ±0 | ±0% | 110,400 |
| 2021/07/29 | 1,451 | 1,501 | 1,440 | 1,477 | +41 | +2.9% | 137,500 |
| 2021/07/28 | 1,437 | 1,468 | 1,423 | 1,436 | -39 | -2.6% | 125,400 |
| 2021/07/27 | 1,515 | 1,515 | 1,431 | 1,475 | -17 | -1.1% | 161,300 |
| 2021/07/26 | 1,518 | 1,523 | 1,471 | 1,492 | -35 | -2.3% | 164,800 |
| 2021/07/21 | 1,503 | 1,571 | 1,503 | 1,527 | +27 | +1.8% | 95,800 |
| 2021/07/20 | 1,515 | 1,548 | 1,498 | 1,500 | -23 | -1.5% | 106,600 |
| 2021/07/19 | 1,552 | 1,571 | 1,512 | 1,523 | -58 | -3.7% | 79,400 |
| 2021/07/16 | 1,556 | 1,602 | 1,552 | 1,581 | +10 | +0.6% | 73,600 |
| 2021/07/15 | 1,623 | 1,623 | 1,557 | 1,571 | -54 | -3.3% | 134,100 |
| 2021/07/14 | 1,583 | 1,651 | 1,583 | 1,625 | +25 | +1.6% | 83,000 |
| 2021/07/13 | 1,647 | 1,656 | 1,600 | 1,600 | -47 | -2.9% | 89,500 |
| 2021/07/12 | 1,685 | 1,690 | 1,631 | 1,647 | +18 | +1.1% | 173,500 |
| 2021/07/09 | 1,529 | 1,630 | 1,522 | 1,629 | +60 | +3.8% | 179,300 |
| 2021/07/08 | 1,640 | 1,640 | 1,552 | 1,569 | -96 | -5.8% | 259,400 |
| 2021/07/07 | 1,628 | 1,674 | 1,600 | 1,665 | +4 | +0.2% | 172,900 |
| 2021/07/06 | 1,644 | 1,677 | 1,575 | 1,661 | +15 | +0.9% | 255,000 |
| 2021/07/05 | 1,700 | 1,722 | 1,635 | 1,646 | -86 | -5% | 220,400 |
| 2021/07/02 | 1,702 | 1,741 | 1,655 | 1,732 | -7 | -0.4% | 345,800 |
| 2021/07/01 | 1,775 | 1,849 | 1,717 | 1,739 | +4 | +0.2% | 495,900 |
| 2021/06/30 | 1,739 | 1,757 | 1,685 | 1,735 | -44 | -2.5% | 390,800 |
| 2021/06/29 | 1,679 | 1,802 | 1,662 | 1,779 | +140 | +8.5% | 759,000 |
| 2021/06/28 | 1,585 | 1,647 | 1,562 | 1,639 | +59 | +3.7% | 269,300 |
| 2021/06/25 | 1,600 | 1,601 | 1,533 | 1,580 | +14 | +0.9% | 242,800 |
| 2021/06/24 | 1,530 | 1,567 | 1,524 | 1,566 | +33 | +2.2% | 170,000 |
| 2021/06/23 | 1,521 | 1,534 | 1,502 | 1,533 | +14 | +0.9% | 104,200 |
| 2021/06/22 | 1,463 | 1,533 | 1,434 | 1,519 | +102 | +7.2% | 206,000 |
| 2021/06/21 | 1,434 | 1,449 | 1,403 | 1,417 | -65 | -4.4% | 195,000 |
| 2021/06/18 | 1,540 | 1,545 | 1,462 | 1,482 | -42 | -2.8% | 263,100 |
| 2021/06/17 | 1,492 | 1,532 | 1,456 | 1,524 | +19 | +1.3% | 235,600 |
| 2021/06/16 | 1,498 | 1,518 | 1,460 | 1,505 | -8 | -0.5% | 206,900 |
| 2021/06/15 | 1,450 | 1,540 | 1,448 | 1,513 | +81 | +5.7% | 426,000 |
| 2021/06/14 | 1,421 | 1,440 | 1,402 | 1,432 | +41 | +2.9% | 157,100 |
| 2021/06/11 | 1,442 | 1,462 | 1,363 | 1,391 | -32 | -2.2% | 291,200 |
| 2021/06/10 | 1,469 | 1,529 | 1,411 | 1,423 | -27 | -1.9% | 362,700 |
| 2021/06/09 | 1,548 | 1,565 | 1,433 | 1,450 | -76 | -5% | 636,800 |
| 2021/06/08 | 1,406 | 1,550 | 1,405 | 1,526 | +149 | +10.8% | 827,900 |
| 2021/06/07 | 1,304 | 1,386 | 1,304 | 1,377 | +75 | +5.8% | 184,900 |
801～
850
件表示中 / 1056件
類似銘柄と比較する
現在ご覧いただいている「モダリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
| ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.55倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
| カイオム | 18,000円 | +2.6% | - | 0.00% | - | 10.61倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| 仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.35倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| ケイファーマ | 73,000円 | -100.0% | - | 0.00% | - | 3.16倍 |
|
慶応大学発医療ベンチャー。ｉＰＳ細胞による再生医療と創薬の２本柱。中枢神経系が得意領域 |
市場注目の銘柄
チャート関連のコラム
